- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03178565
The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU
June 3, 2017 updated by: Augusto Savi, Hospital Moinhos de Vento
The Effects of Mechanical Insufflation-exsufflation for Airway Mucus Clearance Among Mechanically Ventilated ICU Patients: a Randomized Trial
The present study aims to evaluate the effect of mechanical insufflation-exsufflation on airway mucus clearance among mechanically ventilated ICU patients.
A parallel group randomized clinical trial will be conducted in a single mixed medical-surgical ICU of a tertiary hospital in Southern Brazil.
Adult ICU patients with a length of mechanical ventilation >24 hours will be evaluated for eligibility.
Patients will be randomized in a 1:1 ratio to receive respiratory physiotherapy using a mechanical insufflation-exsufflation device (intervention group) or standard respiratory physiotherapy without the use of the mechanical insufflation-exsufflation device (control group).
The primary outcome is the amount of aspirated respiratory mucus (weight in grams) 5 minutes after the finish of respiratory physiotherapy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
170
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90035001
- Recruiting
- Hospital Moinhos de Vento
-
Contact:
- Cassiano Teixeira, MD
- Phone Number: 555133143387
- Email: cassiano.rush@gmail.com
-
Principal Investigator:
- Marcio Camillis
-
Sub-Investigator:
- Cassiano Teixeira, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥ 18 years;
- Admission to the ICU
- Length of mechanical ventilation > 24 hours
- Stable ventilatory and hemodynamic status defined by positive end- expiratory pressure ≤ 8 cm H2O, inspiratory oxygen fraction ≤ 40%, ratio of arterial oxygen partial pressure to fractional inspired oxygen ≥ 150, respiratory rate ≤ 35 breaths per minute, heart rate ≤ 130 beats per minute and systolic blood pressure between 90 and 160 mmHg.
Exclusion Criteria:
- Patients with primary neuromuscular disease.
- Patients in exclusive paliative care.
- Patients with contraindications to the use of mechanical insufflation- Exsufflation device.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention Group
Respiratory physiotherapy using a mechanical insufflation-exsufflation device (CoughAssist)
|
The mechanical insufflation-exsufflation device will be connected in the orotracheal tube.
Four series of insufflation-exsufflation will be conducted.
Each serie will be composed by 10 cycles of alternated insufflation (40 cmH2O) and exsufflation (- 40 cmH2O).
Other Names:
|
|
ACTIVE_COMPARATOR: Control Group
Respiratory physiotherapy according standard of care - without the use of a mechanical insufflation-exsufflation device.
|
Standard chest physiotherapy will be conducted through bilateral thoracic maneuvers (percussion and vibration) followed by manual hyperinflation using a manual resuscitator bag.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amount of aspirated secretion
Time Frame: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.
|
Single measure of weight in grams of the aspirated secretion 5 minutes after the study intervention (mechanical insufflation-exsufflation or standard respiratory physiotherapy).
|
This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Static lung compliance
Time Frame: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.
|
Single measure of the static lung compliance in mL/cm H2O
|
This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.
|
|
Airway resistance
Time Frame: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.
|
Single measure of the airway resistance in cm H2O/L/s
|
This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marcio Camillis, Hospital Moinhos de Vento
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 1, 2016
Primary Completion (ANTICIPATED)
November 1, 2017
Study Completion (ANTICIPATED)
November 1, 2017
Study Registration Dates
First Submitted
April 21, 2017
First Submitted That Met QC Criteria
June 3, 2017
First Posted (ACTUAL)
June 7, 2017
Study Record Updates
Last Update Posted (ACTUAL)
June 7, 2017
Last Update Submitted That Met QC Criteria
June 3, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CoughAssist trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
Hemovent GmbHseleon GmbHRecruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory Failure | Imminent Cardiorespiratory or Respiratory FailureGermany
-
University Hospital, Strasbourg, FranceRecruitingRespiratory Failure | Cardiac FailureFrance
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
University of OsloOslo University HospitalCompletedHypercapnic Respiratory Failure | Type 2 Respiratory FailureNorway
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...RecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureCanada
-
Siriraj HospitalCompletedAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Hospital Sao JoaoCompletedVentilatory Failure | Post-extubation Failure | Persistent Weaning Failure | Secretion Encumbrance | Weak CoughPortugal
Clinical Trials on Mechanical insufflation-exsufflation
-
Insel Gruppe AG, University Hospital BernCompletedNeuromuscular Diseases in ChildrenSwitzerland
-
Assistance Publique - Hôpitaux de ParisTerminatedNeuromuscular Diseases | Amyotrophic Lateral Sclerosis | Duchenne Muscular DystrophyFrance
-
The Catholic University of KoreaCompletedStroke | DysphagiaKorea, Republic of
-
Hospital Sao JoaoCompletedVentilatory Failure | Post-extubation Failure | Persistent Weaning Failure | Secretion Encumbrance | Weak CoughPortugal
-
Odense University HospitalCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...TerminatedCritically IllNetherlands
-
University Hospital, BordeauxSociedad Española de Neumología y Cirugía TorácicaUnknownMechanical Ventilation Complication | Mucus Retention | Mucus; Plug, TracheobronchialFrance
-
Assiut UniversityNot yet recruitingMechanically Ventilated Patients
-
Centre Hospitalier Universitaire VaudoisUniversity Hospital, Geneva; Ligue Pulmonaire VaudoiseCompletedNeuromuscular DiseasesSwitzerland
-
Universidade Federal de Sao CarlosPhilips Respironics; Hospital Estadual Américo BrasilienseUnknownPalliative Care | Mucus HypersecretionBrazil